Science
Mechanism of Action
Carpronium Chloride mimics acetylcholine to stimulate muscarinic receptors on endothelial cells. This trigger produces nitric oxide and prostaglandin E2, which dilates blood vessels and shifts hair follicles from the resting (telogen) phase back into the active growth (anagen) phase.
Research
Clinical Evidence
High confidence5%
Key findings
- 01 A clinical study utilizing a 2% concentration demonstrated a 54.5% improvement rate in women and a 26.7% rate in men experiencing androgenetic alopecia.
- 02 Research involving a 5% concentration showed a significant reduction in areas affected by alopecia areata within 8 to 12 weeks of consistent application.
Transparency
Dusting Analysis
Given its status as a medicinal active in Asia, concentrations below 2% are often insufficient to achieve the vasodilatory effects observed in clinical trials.
The Formula
Formulation
Stability
Highly hygroscopic and prone to hydrolysis; stability is maximized in acidic environments (pH 3.0–5.0).
Synergies
- Nitric oxide boosters
- PGE2 stimulators
- Scalp-penetrating peptides
Conflicts
- Minoxidil (due to pH incompatibility)
- Aqueous formulas with high moisture exposure
Safety
Safety Profile
Approved by Japan's PMDA since 1987. While generally safe for scalp application, its potent vasodilatory effect may cause temporary redness.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-performance medicinal active for targeted hair density and scalp health, provided it is formulated within its strict acidic stability window.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources